1. Home
  2. NAZ vs ENTA Comparison

NAZ vs ENTA Comparison

Compare NAZ & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAZ
  • ENTA
  • Stock Information
  • Founded
  • NAZ 1992
  • ENTA 1995
  • Country
  • NAZ United States
  • ENTA United States
  • Employees
  • NAZ N/A
  • ENTA N/A
  • Industry
  • NAZ Finance/Investors Services
  • ENTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • NAZ Finance
  • ENTA Health Care
  • Exchange
  • NAZ Nasdaq
  • ENTA Nasdaq
  • Market Cap
  • NAZ 139.4M
  • ENTA 129.3M
  • IPO Year
  • NAZ N/A
  • ENTA 2013
  • Fundamental
  • Price
  • NAZ $11.50
  • ENTA $5.58
  • Analyst Decision
  • NAZ
  • ENTA Buy
  • Analyst Count
  • NAZ 0
  • ENTA 4
  • Target Price
  • NAZ N/A
  • ENTA $17.25
  • AVG Volume (30 Days)
  • NAZ 18.3K
  • ENTA 687.8K
  • Earning Date
  • NAZ 01-01-0001
  • ENTA 02-05-2025
  • Dividend Yield
  • NAZ 3.69%
  • ENTA N/A
  • EPS Growth
  • NAZ N/A
  • ENTA N/A
  • EPS
  • NAZ N/A
  • ENTA N/A
  • Revenue
  • NAZ N/A
  • ENTA $67,635,000.00
  • Revenue This Year
  • NAZ N/A
  • ENTA $11.80
  • Revenue Next Year
  • NAZ N/A
  • ENTA $3.99
  • P/E Ratio
  • NAZ N/A
  • ENTA N/A
  • Revenue Growth
  • NAZ N/A
  • ENTA N/A
  • 52 Week Low
  • NAZ $9.22
  • ENTA $5.30
  • 52 Week High
  • NAZ $11.37
  • ENTA $17.80
  • Technical
  • Relative Strength Index (RSI)
  • NAZ 39.88
  • ENTA 26.63
  • Support Level
  • NAZ $11.28
  • ENTA $5.30
  • Resistance Level
  • NAZ $11.55
  • ENTA $6.10
  • Average True Range (ATR)
  • NAZ 0.17
  • ENTA 0.40
  • MACD
  • NAZ -0.03
  • ENTA 0.05
  • Stochastic Oscillator
  • NAZ 26.87
  • ENTA 22.22

About NAZ Nuveen Arizona Quality Municipal Income Fund

Nuveen Arizona Quality Municipal Income Fund is a closed-end management investment company. Its primary investment objective is to provide current income exempt from both regular federal income taxes and Arizona individual income taxes. The fund's secondary objective is to enhance the portfolio value relative to the Arizona municipal bond market through investments in tax-exempt Arizona Municipal Obligations that, in the opinion of the Fund's investment adviser, are underrated or undervalued or represent municipal market sectors that are undervalued.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

Share on Social Networks: